A Study to Evaluate the Pharmacokinetics and Safety of Brivaracetam in Healthy Chinese Subjects
Clinical trial NCT04882540 · COMPLETED
Trial details
- NCT number
- NCT04882540
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-19
- Primary completion
- 2021-06-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.